Clinical Features and Outcomes of Pediatric and Adult Patients Hospitalized for Coronavirus Disease 2019: A Comparison Across Age Strata

作者：Grace X Li, Komal Gopchandani, Noah Brazer, Ashley Tippett, Chris Choi, Hui‐Mien Hsiao, Miriam Oseguera, Abiodun Foresythe, Sanchita Bhattacharya, Venice Servellita, Alicia Sotomayor-González, Jennifer K. Spinler, Mark D. Gonzalez, Dalia Gulick, Colleen S. Kraft, Vyjayanti Kasinathan, Yun F. Wang, Jennifer Dien Bard, Pei Ying Chen, Jessica Flores-Vazquez, Audrey R. Odom John, Paul J. Planet, Sridevi Devaraj, Ananth Annapragada, Ruth Ann Luna, Charles Y. Chiu, Christina A. Rostad · 发表于：Open Forum Infectious Diseases · 年份：2024 · DOI：10.1093/ofid/ofae443 · 被引用次数：6 · 研究领域：COVID-19 Clinical Research Studies、Respiratory viral infections research、Kawasaki Disease and Coronary Complications

Abstract Background Coronavirus disease 2019 (COVID-19) continues to cause hospitalizations and severe disease in children and adults. Methods This study compared the risk factors, symptoms, and outcomes of children and adults hospitalized for COVID-19 from March 2020 to May 2023 across age strata at 5 US sites participating in the Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence consortium. Eligible patients had an upper respiratory swab that tested positive for severe acute respiratory syndrome coronavirus 2 by nucleic acid amplification. Adjusted odds ratios (aOR) of clinical outcomes were determined for children versus adults, for pediatric age strata compared to adolescents (12–17 years), and for adult age strata compared to young adults (22–49 years). Results Of 9101 patients in the Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence cohort, 1560 were hospitalized for COVID-19 as the primary reason. Compared to adults (22–105 years, n = 675), children (0–21 years, n = 885) were less commonly vaccinated (14.3% vs 34.5%), more commonly infected with the Omicron variant (49.5% vs 26.1%) and had fewer comorbidities (P < .001 for most comparisons), except for lung disease (P = .24). After adjusting for confounding variables, children had significantly lower odds of receiving supplemental oxygen (aOR, 0.57; 95% confidenc...